FDA 483 - FAMAR HEALTH CARE SERVICES MADRID SA - April 26, 2024

An FDA inspection of Famar Health Care Services Madrid S.A. in Alcorcon, Madrid, Spain, revealed significant deficiencies in sterile drug product manufacturing procedures and environmental monitoring. The firm also lacked proper written specifications for laboratory controls, indicating a need for comprehensive corrective actions to ensure product quality and safety.